September 23, 2026

Aurelio B. Castrellon, M.D., Joins The Eugene M. and Christine E. Lynn Cancer Institute as a Medical Oncologist

Board-certified medical oncologist Aurelio B. Castrellon, M.D., has joined the Eugene M. and Christine E. Lynn Cancer Institute, part of Baptist Health in Boynton Beach.

Baptist Health South Florida

September 15, 2026

Dana-Farber Research News 09.15.2026

This twice-monthly newsletter highlights recently published research where Dana-Farber faculty are listed as first or senior authors. The information is pulled from PubMed and this issue notes papers published from August 16 - 31.

Dana-Farber

September 03, 2026

Kriti Ahuja, M.D., Joins Baptist Health Wertheim Cancer Institute as a Breast Medical Oncologist

Baptist Health Wertheim Cancer Institute is pleased to welcome Kriti Ahuja, M.D., a board-certified medical oncologist specializing in breast cancer

Baptist Health South Florida

September 02, 2026

Targeting CDK2 Could Boost Immunotherapy Response in Patients With a Wide Range of Cancers, According to Dana-Farber Science

New research from Dana-Farber Cancer Institute scientists suggests that cyclin-dependent kinase 2 (CDK2) inhibitors, which are currently being tested as treatments that slow the growth of a narrow range of cancers, could potentially be more broadly applicable to a wide range of cancers when combined with immunotherapy.

Dana-Farber

September 01, 2026

Dana-Farber Research News 09.01.2026

This twice-monthly newsletter highlights recently published research where Dana-Farber faculty are listed as first or senior authors. The information is pulled from PubMed and this issue notes papers published from August 1 - 15.

Dana-Farber

August 01, 2026

Dana-Farber Research News 08.01.2026

This twice-monthly newsletter highlights recently published research where Dana-Farber faculty are listed as first or senior authors. The information is pulled from PubMed and this issue notes papers published from July 1 - 15.

Dana-Farber

July 24, 2026

The Fear of Having Cancer Never Goes Away

There is a strong history of breast cancer in my family, and the fact that I have dense breasts adding to my risk of developing the disease, kept me vigilant about getting a yearly mammogram screening...

The ASCO Post

July 24, 2026

Neoadjuvant Inetetamab Plus Pyrotinib Evaluated in HER2-Positive Locally Advanced Breast Cancer in China

Neoadjuvant treatment with the HER2-targeted monoclonal antibody inetetamab in combination with the irreversible pan-HER tyrosine kinase inhibitor pyrotinib (inhibits HER1, HER2, HER4) and chemotherap...

The ASCO Post

July 24, 2026

Palliative Care Integrated at Diagnosis Improves QOL for Patients With Breast Cancer in India

Early integration of palliative, or supportive, care at the time of breast cancer diagnosis improved quality of life more than on-demand palliative care in a randomized trial of patients in India. The...

The ASCO Post

July 20, 2026

Study Finds Rising Breast Cancer Incidence Across Asian American, Native Hawaiian, and Pacific Islander Groups

A cross-sectional study found that breast cancer incidence has accelerated among Asian American, Native Hawaiian, and Pacific Islander women between January 1, 2000, and December 31, 2022.

The ASCO Post